Adient (NYSE:ADNT – Get Free Report)’s share price reached a new 52-week low on Tuesday. The company traded as low as $15.05 and last traded at $15.38, with a volume of 37,768 shares traded. The stock had previously closed at $15.15.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on ADNT. Barclays decreased their price target on shares of Adient from $25.00 to $22.00 and set an “equal weight” rating for the company in a report on Friday, October 9th. Wall Street Zen downgraded Adient from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Morgan Stanley dropped their price objective on Adient from $22.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 18th. Deutsche Bank reissued a “buy” rating and set a $28.00 price objective on shares of Adient in a research report on Thursday, August 6th. Finally, Weiss Ratings cut Adient from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday. Seven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $24.40.
Read Our Latest Stock Report on ADNT
Adient Price Performance
The company has a market cap of $1.15 billion, a price-to-earnings ratio of 8.05, a price-to-earnings-growth ratio of 0.19 and a beta of 1.64. The company has a fifty day moving average price of $17.24 and a two-hundred day moving average price of $20.21. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 1.21.
Adient (NYSE:ADNT – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported $0.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.13). Adient had a positive return on equity of 7.35% and a negative net margin of 0.11%. The firm had revenue of $3.73 billion for the quarter, compared to analyst estimates of $3.62 billion. During the same quarter last year, the business earned $0.52 EPS. The company’s revenue for the quarter was up 1.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Adient will post 2.94 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, Director Peter Carlin sold 7,843 shares of the firm’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $19.25, for a total transaction of $150,977.75. Following the completion of the sale, the director owned 38,835 shares of the company’s stock, valued at approximately $747,573.75. This trade represents a 16.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.94% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. Dimensional Fund Advisors LP grew its position in Adient by 5.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,384,904 shares of the company’s stock worth $88,614,000 after acquiring an additional 211,843 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in Adient by 17.2% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,293,353 shares of the company’s stock valued at $46,349,000 after purchasing an additional 336,306 shares during the last quarter. Bank of America Corp DE raised its position in Adient by 61.7% in the 1st quarter. Bank of America Corp DE now owns 792,543 shares of the company’s stock valued at $16,017,000 after purchasing an additional 302,538 shares during the last quarter. Empowered Funds LLC raised its position in Adient by 23.5% in the 1st quarter. Empowered Funds LLC now owns 554,572 shares of the company’s stock valued at $11,208,000 after purchasing an additional 105,435 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Adient by 179.3% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 527,356 shares of the company’s stock worth $10,658,000 after purchasing an additional 338,517 shares in the last quarter. 92.44% of the stock is owned by institutional investors and hedge funds.
About Adient
Adient plc is a global supplier of automotive seating systems and components. Its products include complete vehicle seats, seat structures and mechanisms, foam, and trim for passenger vehicles and commercial vehicles. The company works with automakers to design, engineer, and manufacture seating for vehicles sold around the world. Its operations and customer relationships span multiple major automotive markets. Adient became an independent company in 2016 after separating from Johnson Controls’ automotive seating business.
Further Reading
- Five stocks we like better than Adient
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.
